Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BQ.1.18NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BF.5.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BN.1.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.513NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.338NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.284NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.9.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.498NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.184NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.187NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
D.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AE.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.110.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.342NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.500NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.511NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-4751.81US
B.1.428.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.506NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-20641US
B.1.482NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.335NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.36.36NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.499.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.38NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.116NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.134NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.393NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.381NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
C.32NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AE.8NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.516NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.526NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.279NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FL.15.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
EG.2.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.16.32NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.273NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.4.13 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.358NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
C.28NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.177.60NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.159NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.29NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.510NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.91NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.227NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.555NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.513NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.31NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
HN.4.1.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XACNSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used